In conclusion, our proteomically based results have innovatively revealed that the stat4 rs7574865 polymorphism promotes the occurrence and progression of hepatocellular carcinoma via the Stat4/CYP2E1/FGL2 pathway. This evidence concerns the gene FGL2 and hepatocellular carcinoma.